DG
26
-2
LEG
13
2
CCI
38
2
ICE
62
7
WEC
48
2
LYB
39
2
WHR
42
5
FLR
50
-9
TDC
70
2
EMN
76
4
PFG
52
6
DO
69
9
SJM
36
5
EMR
39
2
REGN
71
6
O
44
2
OXY
46
-2
PNC
52
3
FRT
58
-5
T
44
2
DG
26
-2
LEG
13
2
CCI
38
2
ICE
62
7
WEC
48
2
LYB
39
2
WHR
42
5
FLR
50
-9
TDC
70
2
EMN
76
4
PFG
52
6
DO
69
9
SJM
36
5
EMR
39
2
REGN
71
6
O
44
2
OXY
46
-2
PNC
52
3
FRT
58
-5
T
44
2
Financhill
Back

Oncolytics Biotech 10K Form

Sell
49

ONC.TO
Oncolytics Biotech

Last Price:
1.62
Seasonality Move:
-7.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ONC.TO News And Ratings

See the #1 stock for the next 7 days that we like better than ONC.TO

ONC.TO Financial Statistics

Sales & Book Value

Annual Sales: $310K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.37
Price / Book: 4.38

Profitability

EPS (TTM): -0.41060
Net Income (TTM): $-27.75M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Oncolytics Biotech Earnings Forecast

Key Oncolytics Biotech Financial Ratios

  • The Selling, General & Administrative Expenses for ONC.TO have been equal to 951.61% of Gross Profit Margin.
  • Per Share Earnings over the last 25 years have been positive in 14 years.

Oncolytics Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: TSX
Industry: Biotechnology
Sector: Health Care
Current Symbol: ONC.TO
Website: oncolyticsbiotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ONC.TO Technical Analysis vs Fundamental Analysis

Sell
49
Oncolytics Biotech (ONC.TO) is a Sell

Is Oncolytics Biotech a Buy or a Sell?